Aurinia settles Lupkynis patent litigation with Teva
Reported by Seeking Alpha · seekingalpha.com · August 19, 2026
Teva can’t launch a generic Lupkynis until at least Dec. 7, 2036 under a settlement with Aurinia. Read more here.
What the tape says
What to watch: AUPH (AUPH) faces a legal or regulatory issue — headline risk here is often larger than the eventual financial impact.
Market reaction today: $AUPH -0.48%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.